[O2–17–01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO‐CONTROLLED STUDY OF ABBV‐8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE. (1st July 2017) - Budur, Kumar; West, Tim; Braunstein, Joel B.; Fogelman, Ilana; Bordelon, Yvette M.; Litvan, Irene; Roberson, Erik D.; Hu, Helen; Verghese, Philip B.; Bateman, Randall J.; Florian, Hana; Wang, Deli; et al.